420 related articles for article (PubMed ID: 22052276)
21. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
22. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
[TBL] [Abstract][Full Text] [Related]
23. Daylight photodynamic therapy: the Southern California experience.
Lane KL; Hovenic W; Ball K; Zachary CB
Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
[TBL] [Abstract][Full Text] [Related]
24. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
27. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
[TBL] [Abstract][Full Text] [Related]
28. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S
Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349
[TBL] [Abstract][Full Text] [Related]
29. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.
Goldberg LH; Landau JM; Moody MN; Marquez D; Jih M; Kimyai-Asadi A; Friedman PM; Busch A; Vergilis-Kalner IJ
J Drugs Dermatol; 2012 May; 11(5):593-7. PubMed ID: 22527427
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy.
Vanaman Wilson MJ; Jones IT; Wu DC; Goldman MP
Lasers Surg Med; 2017 Oct; 49(8):738-742. PubMed ID: 28489298
[TBL] [Abstract][Full Text] [Related]
33. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
[TBL] [Abstract][Full Text] [Related]
34. Effect of Expedited Microneedle-Assisted Photodynamic Therapy for Field Treatment of Actinic Keratoses: A Randomized Clinical Trial.
Petukhova TA; Hassoun LA; Foolad N; Barath M; Sivamani RK
JAMA Dermatol; 2017 Jul; 153(7):637-643. PubMed ID: 28514458
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
[TBL] [Abstract][Full Text] [Related]
36. Topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid: randomized controlled trial with six months follow-up.
Buinauskaite E; Maciulaitis R; Buinauskiene J; Valiukeviciene S
J Dermatolog Treat; 2014 Dec; 25(6):519-22. PubMed ID: 24215475
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of ALA-PDT vs blue light in the treatment of acne.
Akaraphanth R; Kanjanawanitchkul W; Gritiyarangsan P
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):186-90. PubMed ID: 17803597
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
[TBL] [Abstract][Full Text] [Related]
39. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
40. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Van der Geer S; Krekels GA
J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
